Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

404 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Trends in mortality in people with HIV from 1999 to 2020: a multi-cohort collaboration.
Tusch E, Ryom L, Pelchen-Matthews A, Mocroft A, Elbirt D, Oprea C, Günthard HF, Staehelin C, Zangerle R, Suarez I, Vehreschild JJ, Wit F, Menozzi M, d'Arminio Monforte A, Spagnuolo V, Pradier C, Carlander C, Suanzes P, Wasmuth JC, Carr A, Petoumenos K, Borgans F, Bonnet F, De Wit S, El-Sadr W, Neesgaard B, Jaschinski N, Greenberg L, Hosein SR, Gallant J, Vannappagari V, Young L, Sabin C, Lundgren J, Peters L, Reekie J; D:A:D cohort study; RESPOND cohort study. Tusch E, et al. Clin Infect Dis. 2024 Apr 26:ciae228. doi: 10.1093/cid/ciae228. Online ahead of print. Clin Infect Dis. 2024. PMID: 38663013
Effectiveness and safety of filgotinib in rheumatoid arthritis patients: data from the GISEA registry.
Fornaro M, Caporali R, Biggioggero M, Bugatti S, De Stefano L, Cauli A, Congia M, Conti F, Chimenti MS, Bazzani C, Perniola S, Atzeni F, Lapadula G, Ferraccioli G, Iannone F; from the GISEA registry. Fornaro M, et al. Among authors: lapadula g. Clin Exp Rheumatol. 2024 May;42(5):1043-1050. doi: 10.55563/clinexprheumatol/b40rv4. Epub 2024 Apr 17. Clin Exp Rheumatol. 2024. PMID: 38634362
Long-term outcomes of bictegravir/emtricitabine/tenofovir alafenamide as first-line therapy and as switch strategy in virologically suppressed persons with HIV: data from the ICONA cohort.
d'Arminio Monforte A, Tavelli A, Di Biagio A, Sarmati L, Marchetti GC, Bai F, Cingolani A, Quiros Roldan E, Mussini C, Lichtner M, Vergori A, Piconi S, Orofino G, Fusco FM, Bandera A, Nozza S, Castagna A, Antinori A; ICONA Foundation Study Group. d'Arminio Monforte A, et al. J Antimicrob Chemother. 2024 Apr 6:dkae081. doi: 10.1093/jac/dkae081. Online ahead of print. J Antimicrob Chemother. 2024. PMID: 38581349
Do we Still Need Eligibility Criteria to Recommend PrEP? Impact of National Prescribing Requirements on Retention in Care and Sexually Transmitted Infections Acquisition.
Rossotti R, Tavelli A, Calzavara D, De Bona A, Muccini C, Moschese D, Caruso E, Soria A, Bossolasco S, Lapadula G, Cernuschi M, Monforte AD. Rossotti R, et al. Among authors: lapadula g. AIDS Behav. 2024 Mar 25. doi: 10.1007/s10461-024-04320-3. Online ahead of print. AIDS Behav. 2024. PMID: 38526636
Heavily treatment-experienced persons living with HIV currently in care in Italy: characteristics, risk factors, and therapeutic options-the ICONA Foundation cohort study.
Lo Caputo S, Poliseno M, Tavelli A, Gagliardini R, Rusconi S, Lapadula G, Antinori A, Francisci D, Sarmati L, Gori A, Spagnuolo V, Ceccherini-Silberstein F, d'Arminio Monforte A, Cozzi-Lepri A; ICONA Foundation Study Group. Lo Caputo S, et al. Among authors: lapadula g. Int J Infect Dis. 2024 Jun;143:106956. doi: 10.1016/j.ijid.2024.01.023. Epub 2024 Mar 5. Int J Infect Dis. 2024. PMID: 38447754 Free article.
Geometry and electronic structure of Yb(III)[CH(SiMe3)2]3 from EPR and solid-state NMR augmented by computations.
Ashuiev A, Allouche F, Islam MA, Carvalho JP, Sanders KJ, Conley MP, Klose D, Lapadula G, Wörle M, Baabe D, Walter MD, Pell AJ, Copéret C, Jeschke G, Pintacuda G, Andersen RA. Ashuiev A, et al. Among authors: lapadula g. Phys Chem Chem Phys. 2024 Mar 13;26(11):8734-8747. doi: 10.1039/d4cp00281d. Phys Chem Chem Phys. 2024. PMID: 38416412 Free PMC article.
Drugs for treating infections caused by non-tubercular mycobacteria: a narrative review from the study group on mycobacteria of the Italian Society of Infectious Diseases and Tropical Medicine.
Calcagno A, Coppola N, Sarmati L, Tadolini M, Parrella R, Matteelli A, Riccardi N, Trezzi M, Di Biagio A, Pirriatore V, Russo A, Gualano G, Pontali E, Surace L, Falbo E, Mencarini J, Palmieri F, Gori A, Schiuma M, Lapadula G, Goletti D; Study Group on Mycobacteria (MYGRO) of the Italian Society of Infectious Diseases and Tropical Medicine (SIMIT).. Calcagno A, et al. Among authors: lapadula g. Infection. 2024 Feb 8. doi: 10.1007/s15010-024-02183-3. Online ahead of print. Infection. 2024. PMID: 38329686 Review.
404 results